Eastover Opens a Brand New $3.3 Million Novo Nordisk Position

Eastover Investment Advisors LLC initiated a new position in Novo Nordisk (NYSE:NVO), acquiring 59,811 shares during the quarter in an estimated $3.32 million trade, according to its October 7, 2025, SEC filing.According to a filing with the U.S. Securities and Exchange Commission dated October 7, 2025, Eastover Investment Advisors LLC established a new position in Novo Nordisk, purchasing 59,811 shares during the quarter. The estimated investment totaled $3.32 million for the period ended September 30, 2025. Novo Nordisk now accounts for 1.4% of the fund’s $229.98 million in reportable U.S. equity holdings as of September 30, 2025.This is a new position for Eastover Investment Advisors LLC, now representing 1.4% of 13F assets under management.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool